We are delighted to introduce the winter edition of European Ophthalmic Review expertly introduced by our new Editor-in-Chief Maurizio Battaglia Parodi.
This edition features a collection of topical review articles covering a range of areas within the ophthalmic field. Richard Gale and colleagues explore the psychosocial factors in the management of the diabetic macular oedema patient with anti-VEGF therapy and Natasha Spiteri and colleagues review the new clinical data and treatment recommendations in the management of corneal neovascularisation.
We hope you enjoy this edition, and find the review articles useful to your daily clinical practice. Submissions are now being accepted to the 2017 summer and winter editions. Please visit our submission system for further information.
Letter from the Editor-in-Chief – European Ophthalmic Review, 2016;10(2):77
It is a great honour and a privilege to be Editor-in-Chief of such a respected publication, a copy of which has always been on my desk. The online version makes it even simpler for ophthalmologists working in any subspecialty to have access to the latest top-quality research and reviews. European Ophthalmic Review has gained a […]
Keratoconus Screening in Primary Eye Care – A General Overview
Keratoconus early detection (screening) and diagnosis requires an in-deep corneal analysis with different techniques available.1 Slip lamp assessment and corneal topography/tomography are the most commonly accepted techniques in eye examination. Corneal topography and corneal tomography are useful terms that distinguish between two different types of corneal examination, so both will coexist and be complementary.2 In […]
The Management of Corneal Neovascularisation – Update on New Clinical Data and Recommendations of Treatment
Corneal neovascularisation (CoNV) is a sight-threatening condition caused by new vessel formation from the limbal vascular plexus and marginal corneal arcades and invasion into the cornea in response to inflammation, infection, trauma and hypoxia.1,2 CoNV may lead to profound visual decline by compromising corneal clarity. Pathologic vessel formation may compromise corneal transparency by blocking and […]
Effective Ocular Biometry and Intraocular Lens Power Calculation
Cataract surgery is currently the most frequently performed surgical technique worldwide. Since the introduction of phacoemulsification by Kelman in 1967, surgical technology and construction of implanted intraocular lenses (IOLs) have undergone considerable improvement. Small, sutureless incisions and the use of foldable intraocular lenses reduced the incidence of complications and surgically induced astigmatism.1,2 Furthermore, the use […]
Diagnostic Tools for Dry Eye Disease
The International Dry Eye Workshop Dry Eye Workshop (DEWS) defined dry eye as “a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance and tear film instability with potential damage of the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the […]
Clinical Research of Ultrasound Ciliary Plasty and Implications for Clinical Practice
Interest in the application of ultrasound as treatment for glaucoma began in the 1980s. Following recent breakthroughs in the field of high-intensity focused ultrasound (HIFU) technology, a new procedure, known as ultrasound ciliary plasty (UCP) has been developed for selective, precise and gentle structural modification of the ciliary body, with sparing of the adjacent ocular […]
Contact Lens Sensor Triggerfish – What Do We Know?
The main risk factor for glaucoma damage is an intraocular pressure (IOP) above an undeterminable threshold value for an individual patient. The IOP is not constant but is subject to multiple physiological and pathological fluctuations. These can vary in magnitude and duration, for example, the pulsation of retinal vessels, Valsalva manoeuvre, changes from upright to […]
The Importance of Ocular, Systemic and Psychosocial Factors in the Management of the Diabetic Macular Oedema Patient with Antivascular Endothelial Growth Factor Therapy
Diabetic macular oedema (DMO) is one of the leading causes of visual impairment in working adults.1 The implications of blinding due to DMO, including the loss of productivity and reduced quality of life (QoL), lead to a considerable socioeconomic burden on communities.2–5 Intravitreal treatment options, particularly with anti-vascular endothelial growth factor (anti-VEGF) agents, have shown […]
Optimal Dose and Cost-effectiveness of Ranibizumab Treatment of Diabetic Macular Oedema
Diabetic macular oedema (DMO) is an increasingly serious healthcare issue and a leading cause of blindness worldwide.1 Of the estimated 415 million people with diabetes globally, 7–12% have signs of DMO and 1–3% have visual impairment as a result.2,3 This burden affects populations in all territories and is likely to increase substantially when the prevalence […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!